The review system is broken – not only by the sheer number of “me too” papers but also by the lack of reviewers who are willing to spend their time on these papers. This is also the result of a new essay Continue reading The system itself is untenable
The Plan S open-access initiative has announced its support for newly emerging ways of producing research papers, in which peer review takes place independently from publication in journals or on platforms.
plan S is widely known for their last major announcement
on September 12, 2018, UBS confirmed a sell rating for shares in Elsevier (RELX). Elsevier stock lost 13% between August 28 and September 19, 2018 alone
so hopefully the stock market will respond again by selling out Elsevier.
Together with many other colleagues I was astonished about the Nestle booth at EAACI / PAAM 2019 conference in Florence.
The advertisement of Nestle for the NAN HA formula (“state-of-the-art routine infant formula“, „proven to reduce the risk of atopic dermatitis“, „long term effects up to 15 years of age“) along with other milk marketing violates recommendations of the WHO and other medical organisations about breast-feeding. None of the claims made is justified from a scientific viewpoint.
Having paid 650 € entry fee for a 3 day conference, it is also not acceptable that Dr Antonella Muraro (Padua) explains in Symposium 9 “Special products for cow’s milk allergy“ that if Nestle would not be sponsoring the event, the congress fees would be even higher.
At present, there is no generally accepted benefit of any baby food on long-term allergy prevention while also the therapeutic benefit is questionable. Commercial baby food may even increase later allergy by including supplements that are itself allergenic.
We therefore recommend a review of the EAACI ethics guidelines of industry sponsorship, and an immediate action against further participation of Nestle at future EAACI allergy congresses.